CONMED Corporation Announces Quarterly Cash Dividend

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, scheduled for payment on April 5, 2022. Shareholders on record as of March 15, 2022 will be eligible for this dividend. This decision underscores the company's commitment to returning value to its shareholders. CONMED specializes in medical technology, providing surgical devices for various specialties, which positions it well within the healthcare sector.

Positive

• Quarterly cash dividend of $0.20 per share enhances shareholder value.
• Payment scheduled before financial results typically supports investor confidence.

Negative

• Ongoing risks related to the COVID-19 pandemic may impact surgical procedures and sales.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on April 5, 2022 to all shareholders of record as of March 15, 2022.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2021 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220228005596/en/

CONMED Corporation

Todd Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When is the dividend payment date for CNMD?

The dividend payment date for CNMD is April 5, 2022.

What is the amount of the dividend declared by CNMD?

The amount of the dividend declared by CNMD is $0.20 per share.

Who will receive the CNMD dividend?

Shareholders of record as of March 15, 2022, will receive the CNMD dividend.

How often does CNMD pay dividends?

CNMD typically pays dividends quarterly.

Is the dividend from CNMD sustainable?

While the dividend has been declared, ongoing risks from the COVID-19 pandemic could affect its sustainability.